VISIPAQUE 320 mg d'I/mL, solution injectable
solution injectable
intra-artérielle;intrathécale;intraveineuse;orale;rectale
Autorisation active
Procédure nationale
Commercialisée
2/8/1995
GE HEALTHCARE
Business Listing - September 04, 2021
This is a premium business listing. Stand out from the competition!